Literature DB >> 26050557

Functional polymorphism rs710218 in the gene coding GLUT1 protein is associated with in-stent restenosis.

Tadeusz Osadnik1, Joanna Strzelczyk2, Kamil Bujak1, Rafał Reguła1, Jarosław Wasilewski1, Martyna Fronczek2, Anna Kurek1, Marcin Gawlita1, Małgorzata Gonera1, Marek Gierlotka1, Andrzej Lekston1, Michał Hawranek1, Krzysztof Myrda1, Andrzej Wiczkowski2, Zofia Ostrowska2, Mariusz Gąsior1, Lech Poloński1.   

Abstract

AIM: To analyze the association between in-stent restenosis (ISR) and polymorphisms in genes coding IGF-1, IGFBP3, ITGB3 and GLUT1, which play an important role in the smooth muscle cell proliferation and extracellular matrix synthesis - the main components of neointima. MATERIALS &
METHODS: We analyzed 265 patients who underwent bare metal stent implantation.
RESULTS: The differences in the occurrence of ISR between genotypes of the analyzed polymorphisms in the IGF-1, IGFBP3 and ITGB3 were not statistically significant. The T/T genotype of the rs710218 polymorphism in the GLUT1 (SLC2A1) gene was more common in the ISR group compared with non-ISR patients (81.1 vs 64.8%; p = 0.02). In a multivariable model the A/A and A/T genotype remained correlated with lower occurrence of ISR (odds ratio: 0.45; 95% CI: 0.21-0.97; p = 0.03).
CONCLUSION: The rs710218 polymorphism in the gene coding GLUT1 protein is a novel risk factor for ISR.

Entities:  

Keywords:  GLUT1; IGF-1; IGFBP3; ITGB3; SLC2A1; glucose transporter; growth factors; polymorphism; restenosis; stent

Mesh:

Substances:

Year:  2015        PMID: 26050557     DOI: 10.2217/bmm.15.36

Source DB:  PubMed          Journal:  Biomark Med        ISSN: 1752-0363            Impact factor:   2.851


  6 in total

Review 1.  The Prognostic Role of Red Blood Cell Distribution Width in Coronary Artery Disease: A Review of the Pathophysiology.

Authors:  Kamil Bujak; Jarosław Wasilewski; Tadeusz Osadnik; Sandra Jonczyk; Aleksandra Kołodziejska; Marek Gierlotka; Mariusz Gąsior
Journal:  Dis Markers       Date:  2015-08-26       Impact factor: 3.434

2.  The association of functional polymorphisms in genes encoding growth factors for endothelial cells and smooth muscle cells with the severity of coronary artery disease.

Authors:  Tadeusz Osadnik; Joanna Katarzyna Strzelczyk; Andrzej Lekston; Rafał Reguła; Kamil Bujak; Martyna Fronczek; Marcin Gawlita; Małgorzata Gonera; Jarosław Wasilewski; Bożena Szyguła-Jurkiewicz; Marek Gierlotka; Mariusz Gąsior
Journal:  BMC Cardiovasc Disord       Date:  2016-11-11       Impact factor: 2.298

3.  Role of glucose metabolism related gene GLUT1 in the occurrence and prognosis of colorectal cancer.

Authors:  Wenming Feng; Ge Cui; Cheng-Wu Tang; Xiao-Lan Zhang; Chuang Dai; Yong-Qiang Xu; Hui Gong; Tao Xue; Hui-Hui Guo; Ying Bao
Journal:  Oncotarget       Date:  2017-05-23

4.  The Relationship between VEGFA and TGFB1 Polymorphisms and Target Lesion Revascularization after Elective Percutaneous Coronary Intervention.

Authors:  Tadeusz Osadnik; Andrzej Lekston; Kamil Bujak; Joanna Katarzyna Strzelczyk; Lech Poloński; Mariusz Gąsior
Journal:  Dis Markers       Date:  2017-07-24       Impact factor: 3.434

5.  Polymorphism in the HaeIII single nucleotide polymorphism of the SLC2A1 gene and cardiovascular disease in the early type 2 diabetes mellitus.

Authors:  Dong-Hwa Lee; Gun Woo Won; Yong Hee Lee; Jong Sung Shin; Eu Jeong Ku; Tae Keun Oh; Hyun Jeong Jeon
Journal:  Diab Vasc Dis Res       Date:  2021 Sep-Oct       Impact factor: 3.291

6.  The Relationships between Polymorphisms in Genes Encoding the Growth Factors TGF-β1, PDGFB, EGF, bFGF and VEGF-A and the Restenosis Process in Patients with Stable Coronary Artery Disease Treated with Bare Metal Stent.

Authors:  Tadeusz Osadnik; Joanna Katarzyna Strzelczyk; Rafał Reguła; Kamil Bujak; Martyna Fronczek; Małgorzata Gonera; Marcin Gawlita; Jarosław Wasilewski; Andrzej Lekston; Anna Kurek; Marek Gierlotka; Przemysław Trzeciak; Michał Hawranek; Zofia Ostrowska; Andrzej Wiczkowski; Lech Poloński; Mariusz Gąsior
Journal:  PLoS One       Date:  2016-03-01       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.